CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer – GlobeNewswire (press release)
Analyst Ratings |
CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the … CRISPR Therapeutics (CRSP) Names Michael Tomsicek as CFO Crispr Theraptc to Post Q1 2018 Earnings of ($0.67) Per Share, SunTrust Banks Forecasts (CRSP) Crispr Theraptc (CRSP) Sees Large Increase in Short Interest |
